Tranquilli Financial Advisor LLC Buys 171 Shares of Elevance Health, Inc. (NYSE:ELV)

Tranquilli Financial Advisor LLC lifted its holdings in shares of Elevance Health, Inc. (NYSE:ELV) by 14.1% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 1,387 shares of the company’s stock after buying an additional 171 shares during the period. Tranquilli Financial Advisor LLC’s holdings in Elevance Health were worth $512,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the stock. Raelipskie Partnership bought a new position in Elevance Health during the third quarter worth about $26,000. PSI Advisors LLC acquired a new stake in Elevance Health in the third quarter valued at approximately $27,000. Eastern Bank bought a new position in shares of Elevance Health during the third quarter valued at $31,000. Crews Bank & Trust bought a new stake in shares of Elevance Health in the 4th quarter valued at about $34,000. Finally, Dunhill Financial LLC raised its holdings in Elevance Health by 57.8% during the 3rd quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock worth $37,000 after purchasing an additional 26 shares during the last quarter. 89.24% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ELV has been the topic of several research reports. Wells Fargo & Company dropped their price objective on shares of Elevance Health from $483.00 to $478.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Royal Bank of Canada decreased their price objective on Elevance Health from $585.00 to $478.00 and set an “outperform” rating for the company in a report on Friday, October 18th. Raymond James set a $485.00 target price on Elevance Health in a research report on Friday, October 18th. Argus restated a “hold” rating and set a $405.40 price objective on shares of Elevance Health in a research report on Wednesday, January 29th. Finally, UBS Group lowered their price objective on shares of Elevance Health from $605.00 to $555.00 and set a “buy” rating for the company in a report on Friday, October 18th. Three analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $517.03.

Elevance Health Trading Up 2.5 %

Elevance Health stock opened at $405.54 on Tuesday. Elevance Health, Inc. has a 52 week low of $362.21 and a 52 week high of $567.26. The stock has a 50-day moving average price of $386.50 and a 200 day moving average price of $456.70. The company has a current ratio of 1.45, a quick ratio of 1.50 and a debt-to-equity ratio of 0.71. The stock has a market cap of $94.05 billion, a PE ratio of 15.84, a P/E/G ratio of 1.19 and a beta of 0.83.

Elevance Health (NYSE:ELV) last issued its quarterly earnings results on Thursday, January 23rd. The company reported $3.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.80 by $0.04. Elevance Health had a net margin of 3.38% and a return on equity of 18.28%. Equities research analysts predict that Elevance Health, Inc. will post 34.07 earnings per share for the current fiscal year.

Elevance Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 25th. Investors of record on Monday, March 10th will be given a $1.71 dividend. This is a positive change from Elevance Health’s previous quarterly dividend of $1.63. The ex-dividend date is Monday, March 10th. This represents a $6.84 dividend on an annualized basis and a dividend yield of 1.69%. Elevance Health’s dividend payout ratio (DPR) is 25.46%.

Elevance Health Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.